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Abstract: Retinoic acid signaling is required at several steps during the development of  
the spinal cord, from the specification of generic properties to the final acquisition of 
neuronal subtype identities, including its role in trunk neural crest development. These 
functions are associated with the production of retinoic acid in specific tissues and are 
highly dependent on context. Here, we review the defects associated with retinoic acid 
signaling manipulations, mostly in chick and mouse models, trying to separate the different 
processes where retinoic acid signaling is involved and to highlight common features, such 
as its ability to promote transitions along the neuronal differentiation cascade. 
Keywords: retinoic acid; spinal cord; neural tube; axis elongation; neural crest;  
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1. Introduction 
The spinal cord is generated from the caudal part of the neural plate at early stages of development. 
In contrast to other regions of the central nervous system (CNS), such as the brain, the spinal cord 
develops progressively over a long period of time as the embryonic body axis extends in a head to tail 
sequence. Initially, the neural plate is induced by signals coming from the underlying hypoblast and 
the organizer (Hensen’s node in chicken and node in mice) and its derivatives [1]. The early neural 
plate will then be regionalized to adopt rostral (forebrain) or more caudal fates (midbrain, hindbrain 
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and spinal cord) in response to signals coming from the node and newly formed mesodermal cells that 
emerge during gastrulation from the primitive streak (PS)/marginal zone [2]. 
The presumptive spinal cord territory corresponds to the epiblast region located at either side of the 
primitive streak and the node [3–5]. This region, known as the caudal stem zone or caudal lateral 
epiblast [6], also contributes to paraxial mesoderm for some time and requires further signaling to 
acquire a complete rostro-caudal (R-C) and dorso-ventral (D-V) repertoire of identities. At the borders 
between the caudal neural plate and the non-neural ectoderm, the trunk neural crest cell (NCC) 
territory is specified.  
One of the signals involved in several processes in spinal cord development (from early patterning 
to neurogenesis and neuronal subtype specification) is retinoic acid (RA). In this review, we will 
discuss how RA signaling is used at different steps reiteratively in the progressive specification and 
differentiation of both spinal cord and trunk NCCs and how it interacts with other signaling pathways. 
In particular, we stress how RA counteracts the effect of FGF, which maintains cells in a more multipotent 
and undifferentiated state, and promotes the transition to subsequent differentiation states. 
Several key RA signaling-deficient models have been used and will be discussed in the following 
sections. Vitamin A (the precursor of RA)-deficient (VAD) embryos are produced from quails reared 
with a restricted retinoid diet [7] and have undetectable levels of retinoids [8], whereas Raldh2 mouse 
knock-out mutants have very reduced RA signaling, according to the analysis of RA activity  
reporters [9,10], and die before midgestation (E10.5). This lethality can be overcome by supplementation 
with retinoids during the lethality time window [9,11] or through the use of conditional Raldh2−/− 
mutants [12,13]. Retinoic acid receptor (RAR) agonist and antagonists have also been used in embryo 
or explant cultures [14], and modified retinoic acid receptors have been used in chicken electroporation 
experiments, either to activate the pathway with constitutively active forms or to block it with 
deletions that behave as dominant negatives over the endogenous RAR (DN-RAR) [14]. 
2. RA Signaling Gradients during Axis Elongation 
2.1. Sites of Active RA Signaling during Spinal Cord Elongation: Differential Expression of Key 
Components of the Pathway 
In vertebrates, the primary body axis is generated from head to tail through a similar principle, 
consisting in the progressive addition of new tissue at the posterior end of the embryo (reviewed  
in [2,6]). This process requires a highly controlled balance between the maintenance of progenitor 
pools and the continuous production of cells that form the different body structures. The neck and 
trunk structures (spinal cord, notochord, somites and lateral plate mesoderm) are progressively 
generated from the early caudal embryonic region as the extension of the body axis proceeds. Different 
signaling molecules are involved in the coordinated development of this region, and in particular, RA 
is an important signal for the spatio-temporal control of caudal development. 
RA is synthesized from vitamin A, also known as all-trans-retinol, via two consecutive enzymatic 
reactions [15]. In the first reaction, all-trans-retinol is oxidized to all-trans-retinaldehyde (retinal). 
During development, this reaction is controlled mostly by retinoldehydrogenase-10 (Rdh10; [16,17]) 
that is expressed, amongst others regions, in the floor plate and somites adjacent to the developing 
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spinal cord [18,19]. However, mutations in Rdh10 do not seem to affect spinal cord development,  
and RA signaling is still retained at the ventral neural tube [17,20], indicating that other retinol 
dehydrogenases could be acting in the neural tube.  
At least two other dehydrogenases are involved in retinal production, Rdhe2 (Sdr16c5) and Cyp1B1 
(cytochrome p450 1B1, a monomeric monooxygenase). Rdhe2 is expressed in the notochord, 
underlying the developing neural tube. In Xenopus embryos, knocking down Rdhe2 results in 
phenotypes consistent with RA deficiency, such as defects in anterior neural tube closure, disruption of 
somitogenesis and a curved body axis with a bent tail [21]. Cyp1B1 is expressed at gastrulation stages 
in the primitive streak and caudal epiblast and later in somites, and it is sufficient to efficiently oxidize 
retinol to retinal and, subsequently (to a lesser extent), to RA [22]. Furthermore, Cyp1B1 overexpression 
can alter the R-C and D-V patterning of the hindbrain and spinal cord in a manner that is consistent 
with the promotion of RA activity [22]. However, it is not clear if Cyp1B1 could be also playing a role 
in other species apart from the chicken. The expression pattern of Rdhe2 (notochord) and Cyp1B1 
(somites) suggests that RA biosynthesis for CNS (at least its first step) may occur in the adjacent axial 
and paraxial mesoderm. 
The second reaction is controlled by three retinaldehyde dehydrogenases that generate RA (Raldh1, 
Raldh2 and Raldh3), each of which is present in specific spatiotemporal domains during embryogenesis. 
They are the only enzymes involved in the second step of RA synthesis, at least prior to stage E10.5 of 
mouse development [9,10]. Raldh2 is the more extensively studied of the three, the earliest expressed 
and the only one associated with spinal cord development. At gastrulation stages, Raldh2 is expressed 
transiently in primitive streak and node cells (Figure 1a) and in paraxial mesendoderm underlying  
the caudal neural plate (future hindbrain and spinal cord) [23–26]. As somitogenesis is initiated,  
its expression is progressively activated during axial elongation in the rostral-most presomitic 
mesoderm (PSM) and is maintained in somites (although, later downregulated in the first four somites; 
Figure 1b,c) [24,26]. Raldh2−/− mouse mutants die before midgestation (E10.5) from defective heart 
morphogenesis and exhibit numerous abnormalities, including alterations in hindbrain patterning, 
motor neuron specification and early forebrain development [9,10,27,28]. Some of these abnormalities 
can be rescued by transient maternal RA supplementation from E7.5 to E8.5–9.5 [9,11]. 
Other enzymes involved in the metabolism of RA are members of the Cyp26 family that are 
capable of degrading RA to inactive forms. Cyp26a1 is expressed in the caudal stem zone and is 
progressively downregulated as the embryo extends [29–32]. These complementary expression 
patterns of Raldh2 and Cyp26a1 allow high RA levels at somitic levels and the maintenance of an RA 
free caudal-most region. 
Both retinol and retinoic acid are normally bound within the cytoplasm to cellular retinol and 
retinoic acid binding proteins (CRBP, CRABPI and II), which play a role in retinoid traffic and may 
also work in modulating the availability of retinoic acid, as shown in the zebrafish hindbrain [33]. 
However, CRBP and CRABP mutant mice do not show overt phenotypes [34,35]. Both types of 
protein are expressed in the spinal cord in progenitors or in differentiating neurons [36–40], but their 
roles in spinal cord have not been specifically addressed. 
RA binds to nuclear RA receptors (RARα, β, and γ) and peroxisome proliferator-activated receptors 
(PPAR β/δ), which act as heterodimers with retinoid X receptors (RXRα, β, and γ) to activate 
transcription of target genes [41,42]. In Hamburger and Hamilton (HH) stage 10 chick embryos, 
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RXRα, RARα and RARβ are expressed in the spinal cord flanked by somites and their expression 
decline at presomitic levels, while RXRγ and RARγ expression extends more caudally into the caudal 
neural plate and is also detected in the primitive streak [43–45]. 
Thus, the combination of Raldh2 and RA receptor expression creates an R-C gradient of RA activity 
in the neural tube and paraxial mesoderm and suggests a paracrine mode of RA action [15], which 
implies that RA is synthesized in the trunk mesoderm and diffuses to exert transcriptional control in 
the CNS. This is consistent with RA levels measured by HPLC in chick [46], by genetically encoded 
probes for RA in zebrafish [47] and with active RA signaling detected in mice with a retinoic acid 
response element (RARE)-lacZ transgene [48,49], first in the caudal epiblast and then in the 
developing spinal cord adjacent to somites (Figure 1a–c). At later stages, the cervical/brachial and 
lumbar spinal cord regions stand out for their high RA pathway activation levels [50] (Figure 1i). 
2.2. Mechanisms Regulating the Activation of RA Signaling during Axis Elongation: An RA-FGF-Wnt 
Gene Regulatory Network  
A key feature of spinal cord development is the progressive activation of the RA signaling pathway 
at somitic levels coupled to downregulation of FGF signaling at presomitic and caudal levels. These 
pathways have been proposed to constitute a signaling switch that controls the R-C sequence of 
mesodermal and neural development [45,51]. In addition, the interaction between the RA and  
FGF pathways is controlled through series of cross-regulations that also involve the Wnt signaling 
pathway [6]. 
On the one hand, Fgf8 is expressed as a caudal (high) to rostral (low) gradient in caudal tissues  
(Figure 1a–c), and the FGF pathway is essential for maintaining an undifferentiated ‘stem’ zone 
adjacent to the regressing primitive streak [5,52]. In the neural tube, FGF8 is a general repressor of 
differentiation, and the attenuation of the pathway is required for neural differentiation, including 
ventral patterning (explained in more detail in Sections 3 and 4; [45,53]). Additionally, the FGF8 
gradient controls the position of somite boundaries in the presomitic mesoderm [51]. One important 
function of FGF is the blockade or attenuation of RA signaling, as several steps in the RA pathway are 
influenced by FGF signaling. Thus, FGF4/8 can block the activation of Raldh2 transcription in 
presomitic mesoderm explant cultures and in whole embryos [45]. FGF4/8 can also downregulate the 
expression of the RARβ receptor in the spinal cord [54], which may reflect the ability of FGF to 
interfere with the RA feed-forward loop (as RARβ is also activated in response to RA signals). In 
addition, the FGF receptor I (FGFRI) is required for the expression of Cyp26a, the RA degrading 
enzyme in the caudal-most region [55]. 
This indicates that FGF may restrain RA activity to somitic levels, but downregulation of FGF 
signaling alone is not sufficient to extend the Raldh2 domain caudally [54,55]. Interestingly, FGF 
signaling not only blocks Raldh2 expression, but also plays an indirect role in its activation. FGF8 
activates Wnt8C in the caudal stem zone, which persists at presomitic levels once Fgf8 expression is 
extinguished and then activates Raldh2 in the underlying somites [54]. The simultaneous blockade of 
FGF signaling with the activation of the Wnt canonical pathway can increase the levels of Raldh2 
expression [54], but cannot extend its expression caudally, suggesting that other pathways are required 
for proper Raldh2 expression. 
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On the other hand, RA can downregulate Fgf8 expression in caudal explants, and the analysis  
of VAD quail embryos and Raldh2−/− mouse mutants reveals that a lack of RA signaling leads  
to an anterior expansion of the FGF8 domain along the PSM and to the formation of smaller  
somites [45,56–58]. This role of RA in repressing Fgf8 may be limited to a short period of time when 
the somitogenesis molecular clock initiates [59]. In conclusion, although the cross-regulation between 
the two pathways can explain many aspects of the process of axis elongation, the knowledge about the 
molecular mechanism linking both pathways is very limited, and more focused and high-throughput 
analysis would be required. 
2.3. RA in the Control of Trunk-Tail Transition and Axis Termination 
An important aspect to consider in the process of axis elongation is the transition from trunk to tail. 
Whereas the trunk tissues are generated from all three germ layers and give rise to most of the vital 
and reproductive organs, the tail is derived from paraxial mesoderm and ectoderm and is basically 
composed of vertebrae, its associated muscles and caudal spinal cord, lacking motor roots and 
peripheral ganglia [60]. The trunk-tail transition is associated with a change in the mode of axial 
extension. Thus, while trunk formation is mainly driven by the PS [61,62]; tail formation is associated 
with the activity of the tail bud, where axial progenitors from the PS are relocated into a structure 
named the caudal neural hinge (CNH; [62]). This transition also affects the mechanism of neural tube 
formation that changes from neural plate folding or primary neurulation to neural tube cavitation in 
secondary neurulation [6]. 
Recently, it has been revealed that Gdf11 mutants exhibit delays in the specification of tail 
structures due to abnormalities observed in the PS to CNH transition [63]. Cyp26a1 expression levels 
are reduced in the posterior end of Gdf11 mutant embryos at the time of that transition. This could be 
the origin of an uneven RA distribution along the rostro-caudal axis. Moreover, the inhibition of RA 
signaling produces a significant reversion of the abnormalities observed in the PS to CNH transition 
observed in Gdf11 mutants, placing RA signaling as a key regulator of that transition. 
Finally, at a specific point during development, body axis elongation ceases, and this must involve 
the regulated differentiation and/or loss of axial stem and mesoderm progenitor cells. The pathway 
responsible for that cessation seems to be RA signaling. Exposure to exogenous RA can arrest body 
elongation by inhibiting the expression of Wnt3a [64–66]. More recently, it has been determined that 
rising retinoid signaling in the late chicken tail bud causes the loss of FGF signaling and, 
consequently, loss of Brachyury gene expression from the axial stem cell population and presumptive 
mesoderm cells [39]. These events are followed by local cell death in the tail bud, which can be 
reduced by the attenuation of RA signaling in an FGF-independent way, and that ultimately leads to 
the cessation of body elongation. Moreover, at this late stage, FGF signaling in the tail bud no longer 
opposes retinoid synthesis and activity. However, it is not clear how the RA signaling pathway escapes 
from the control exerted by FGF signaling [39]. 
In the case of the mouse embryo, which, in contrast to human or chicken, retains the tail, the 
mechanism involved in the attenuation of FGF signaling as elongation ceases could be different. While 
RA is required for caudal regression in chick promoting cell death, recent data suggest that RA is not 
synthesized in the mouse tail bud [67]. However, the understanding of differences in axis elongation 
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cessation between different species requires further mechanistic analysis. Moreover, it will be 
interesting to determine if the same signaling dynamics are deployed to arrest the elongation of other 
axial structures, such as the limb and beak, which are also truncated by an excess of RA [68,69]. 
3. RA Controlling Early Neurogenesis in Spinal Cord 
The initial exposure of the epiblast to RA occurs at the time when neural specification is being 
stabilized in the caudal neural plate [1]. RA has not been implicated in early neural induction steps  
in vitro [70] or in vivo, as neural induction occurs in Raldh2−/− embryos [10,49,56]. However, the 
maintenance of induced neural tissue in caudal regions may have some dependency on retinoid 
signaling. For instance, Raldh2−/− mutants show early caudal patterning defects, with an expansion of 
the primitive streak and mesodermal markers at the expense of markers of the prospective 
neuroepithelium, such as the pan-neural marker Sox2, as early as E7.5 [49]. However, this requirement 
may be specific to a time window, as explants of presumptive chick spinal cord at gastrulation stages 
exposed to RAR/RXR inhibitors display normal Sox2 levels [23]. 
Moreover, RA deficiency in the neural tube is also associated with a reduced number of cells 
expressing the mitosis marker phospho histone H3 in quail and zebrafish embryos [71,72], indicating 
that RA deficiency probably causes defects in cell proliferation. Even in vitro, RA increased by 45% 
the number of BrdU incorporating cells in ventral neural tube explants from brachial levels, suggesting 
that retinoids increase the number of motor neuron progenitors at limb levels [73]. 
Once the neural specification step is consolidated, progressive activation of RA signaling in the 
spinal cord is required for spinal cord differentiation, as shown in VAD quails that have a reduced 
number of neurons in the spinal cord (Figure 1d) [74]. Using RAR/RXR antagonists in vitro, VAD 
quails or the Raldh2−/− mutant, a dramatic reduction in early neurogenesis was observed, which 
included a reduction in the number of cells expressing the proneural genes, Ngn1 and Ngn2, the lateral 
inhibition gene, Hes5, and the early postmitotic neural markers, Delta1 and NeuroM [45,49]. 
Moreover, the VAD neural tube possesses very few or no CRABP1+ cells, a group of early-born 
interneurons [45]. 
The expression of Delta1 has been shown to be resumed in 14-somite stage Raldh2−/−  
embryos [49], and the requirement for RA may thus be limited to the early produced neurons labeled 
with CRABP1 [45]. The requirement of RA to promote neurogenesis could be due to its action at 
several steps in the sequence, leading to neuronal differentiation. First, RA is required for the 
expression of Sox1 and Sox3 [75], two important genes for the maintenance and differentiation of 
progenitors before the onset of neurogenesis [76]. RA is also required for the expression of genes 
primarily involved in the specification of progenitor domains along the D-V axis but, also with a role 
promoting neurogenesis (see Section 4). Additionally, a regulatory region in the Ngn2 locus containing 
two RARE elements required for transgene activity have been identified [77], and thus, there may also 
be a direct regulation of proneural genes by RA. 
Furthermore, stimulation of the RA pathway in prospective spinal cord explants leads to an increase 
in the number of NeuroM expressing cells, indicating that RA is not only required, but it can drive 
neurogenesis in the spinal cord [45]. The search for genes activated by RA in the spinal cord identified 
GDE2, an interesting gene first expressed as cells transition to the postmitotic state and later maintained 
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in differentiating neurons [78]. GDE2 promotes neuronal differentiation acting non-autonomously by 
downregulating Notch signaling in neighboring progenitor cells, and therefore, part of the function of 
RA in neurogenesis may be mediated through this indirect mechanism [79]. 
4. RA in the Acquisition of Dorso-Ventral Identities 
The acquisition of neuronal subtype identities along the D-V axis in the spinal cord is initiated at 
the progenitor stage by the restricted expression of transcription factors in specific domains along this 
axis. In addition, the identity of neurons derived from a particular D-V domain can be further 
stabilized and even diversified, either by signaling factors secreted by adjacent tissues, or generated 
within the neural tissue (including differentiating neurons), or by lateral inhibition mechanisms. RA 
seems to be playing a role at both progenitor and postmitotic neuron specification stages. 
4.1. Ventral Patterning of Progenitors and Acquisition of Motor Neuron Identity 
As mentioned above, although all cells of the presumptive spinal cord may have been transiently 
exposed to RA at gastrulation stages, a subsequent exposure to RA occurs later in a progressive rostral 
to caudal way. This occurs at the time when the neural tube is patterned along its D-V axis by secreted 
signals provided by the ventral notochord and floor plate, such as Shh, and by dorsal signals provided 
by Wnts and BMP. According to the current model, the extracellular gradient of Shh results in the 
graded distribution of the Gli transcriptional factors within responding cells, with those cells located 
near the source containing high levels of Gli activators and low Gli repressors and the converse for 
those further away from the source [80]. As a consequence, Gli responsive genes, such as the 
homeobox (Nkx2.2, Nkx6.1, Nkx6.2, Irx3, Pax6, Dbx1, Dbx2) and bHLH (Olig2) encoding genes, are 
expressed in restricted domains. Specific combinations of these transcription factors define the 
progenitors of four interneuron subtypes and motor neurons (MNs), named p0, p1, p2, pMN and p3, 
from intermediate to more ventral positions [84] (Figure 1e). 
It has been shown that RA is required for the expression of some (but not all) ventral patterning 
genes. Thus, Olig2 and Pax6 (involved in pMN) are dramatically downregulated in VAD quails [45,81], 
in chick neural tubes electroporated with DN-RAR or with Cyp26a [82], in Raldh2−/− mutant  
mice [49,56,83] and in zebrafish embryos treated with DEAB, a Raldh inhibitor that prevents  
the synthesis of RA [72]. A reduction of Irx3 and Nkx6.2 (involved in p2 [84] and p1 [85] 
specification, respectively) has been described in VAD quails [45,81], and the expression of Dbx1 and 
Dbx2 (involved in the specification of p0 and p1 progenitors) can be blocked with RAR/RXR 
antagonists [86]. 
RA is required both for the expression of genes that are activated by Shh (Class II, such as Olig2 
and Nkx6.2) and of those repressed by Shh signaling (Class I, such as Pax6 and Irx3), and therefore, its 
activity cannot be explained by the simple action on the Shh pathway. Furthermore, a Shh-dependent 
gene, such as Nkx6.1, does not require RA, as it is expressed in VAD quails and in Raldh2−/− mutant 
embryos [45,56], suggesting that RA is acting differently on each ventral gene. Still, part of the 
requirement of RA on ventral genes could be the consequence of reduced Shh signaling, as Raldh2−/− 
mutant mice have decreased sensitivity to Shh signals in culture at late gastrulation stages [49] and 
decreased Shh expression in the floor plate has been described in Raldh2−/− mutants [49] and to a 
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lesser extent in VAD quails [74]. However, decreased Shh has also been associated with over 
activation of the RA pathway [22], suggesting that the regulation of Shh by RA is complex and may 
depend on precise levels of RA. In any case, all of these results suggest that the effect of RA loss is not 
that of a general blockade of Shh signaling. 
One interesting possibility is that RA regulates ventral genes through its repressive action  
on Fgf8 [45,56], as it has been shown that Pax6, Irx3 and Nkx6.2 are repressed by the FGF  
pathway [53,82,87]. However, other mechanisms must be in place, as Fgf8 expression is not completely 
expanded rostrally in VAD quails in regions where the expression of ventral genes is affected [45].  
Recently, it has been shown that coincident with the transcriptional onset of key differentiation 
genes, the chromatin around the Pax6 and Irx3 loci undergoes both decompaction and displacement 
towards the nuclear center [58]. This does not occur in Raldh2−/− mutant embryos, probably due to the 
persistence of ectopic FGF signaling, as the inhibition of the FGFR signaling in Raldh2−/− mutant 
embryos restores chromatin decompaction and nuclear positioning of both Pax6 and Irx3 loci. 
However, Pax6 transcription is not rescued in these conditions, indicating that RA could play two 
roles, one downregulating FGF signaling to allow for chromatin decompaction of the Pax6 and Irx3 
locus and an additional role in the transcriptional activation of Pax6. 
In that sense, gene regulatory regions driving Pax6, Nkx6.2 or Olig2 expression in their normal 
ventral domain have been identified [88], but the presence of functional RARE has not been 
determined yet. Regulation of ventral genes by RA may also be related to other proteins involved in 
their transcriptional regulation, such as SoxB1 (Sox1, Sox2 and Sox3) transcription factors [88]. 
Although Sox2 is expressed in RA-deficient conditions [49], the expression of Sox1 and Sox3 is 
greatly downregulated in VAD quails, and this may also contribute to the downregulation of many of 
the ventral patterning genes, although this has not been examined yet [75]. Additionally, as several of 
the ventral genes are involved in cross-regulatory networks, the effect of RA may be indirect for some 
of them [84,89]. 
As discussed in Section 3, RA is required for early neurogenesis and neuronal differentiation,  
but a requirement for specific neuronal subtypes has also been shown (Figure 1g). A dramatic  
decrease in Isl1+ and Mnr2+ MNs is observed in VAD quails [81] and in DN-RAR electroporation 
experiments [82]. This could be a consequence of the RA requirement for Olig2 expression in 
progenitors, but in fact, RA is also acting after Olig2 to promote the MN fate [82]. RA signaling 
cooperates with Ngn2 to activate MN specific genes, such as Hb9, and, therefore, promotes MN 
differentiation. This has been shown to be mediated by the formation of an RAR-Ngn2 complex bound 
to the regulatory region of Hb9, which upon RA binding, is capable of recruiting cofactors, such as the 
histone acetyl-transferase CBP and activate transcription [90]. 
V0, V1 and V2 interneurons (defined by the expression of Evx1/2, En1 and Chx10, respectively) 
are diminished in RA compromised situations, confirming that RA is required for those neuronal 
subpopulations [81,82]. In the case of V0, RA seems to be required at two stages; first to control the 
expression of progenitor proteins and, subsequently, for the specification of V0 interneurons derived 
from the Dbx domains [86]. 
A role for RA signaling has also been shown in the most ventral neuron producing domain (p3) that 
express the progenitor domain marker, Nkx2.2. Progenitors of the subtype p3 require RA to give rise 
to the spinal cord-specific V3 interneurons instead of the 5HT-expressing neurons (characteristic of 
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hindbrain levels). Experiments with DN-RAR and constitutively active RAR have shown that RA 
promotes the activity of the Notch receptor within the p3 domain, which, in turn, decreases (but does 
not eliminate) Ascl1 expression, favoring V3 interneuron identity [91]. 
Overall, it seems clear that RA signaling is crucial for the development of all ventral neuronal cell 
types and that its activity may work through different mechanism along the ventral axis. 
4.2. Dorsal Patterning of Progenitors 
Dorsal patterning of the spinal cord requires the restricted expression of transcription factors 
regulated by dorsal BMP and Wnt signaling molecules [92,93]. The analysis of VAD quails and 
Raldh2−/− mutant embryos has shown that RA is important for the expression of dorsal specific genes, 
such as Pax3, Pax7, Msx2, Wnt1, Wnt3A, BMP and BMP7 [49,81,94], suggesting the role of RA in 
dorsal progenitor specification. Pax3 and Pax7 are the earliest expressed dorsal-specific transcription 
factors and are initially present along the R-C axis of the spinal cord primordium [45]. Their 
downregulation in VAD quails suggests that their expression may require the initial exposure of the 
spinal cord territory to RA from the early paraxial mesoderm (Figure 1a). The analysis of Pax3 and 
Pax7 expression following DN-RAR electroporation in the developing neural tube would help 
ascertain whether RA signaling is required only initially for their onset or also for the maintenance of 
their expression. Other dorsal genes, such as Msx2, Wnt1 and Wnt3A, are activated in a rostral to 
caudal progression, and their depletion in VAD quails may reflect either a requirement for  
somite-derived RA or a consequence of an early requirement (see also Section 5 on the role of RA in a 
particular dorsal cell population, the trunk neural crest). Interestingly, the expression of many of the 
dorsal genes (Pax3, Pax7, Msx2, Wnt1, Wnt3A, BMP4, BMP7) in older VAD quails is exclusively 
downregulated at the rostral half of the spinal cord [81], suggesting that there is a stronger requirement 
for RA at those levels, which may be related to its role in the establishment of rostro-caudal identities 
discussed in Section 6. As Wnt and BMP signals are responsible for the expression of most dorsal 
genes, it would be important to determine which is the most directly affected by RA signaling. 
The activation of the RA pathway within spinal cord progenitors is also dynamic and  
heterogeneous [9], reflecting the existence of restricted sources of RA production and degradation. 
Raldh2 is expressed in the roof plate of chick at stages HH19–29 [31,73], while the RA degradation 
enzyme, Cyp26a, is produced from the dorsal neural tube from chick stage HH12-on [31]. In addition, 
other non-Raldh2 RA sources have been suggested to activate RA signaling at floor plate, ventral and 
dorsal-intermediate levels [9,11] and may contribute to the RA levels in the neural tube necessary for 
D-V patterning, although their specific role has not been shown yet. 
5. RA in Trunk Neural Crest  
Early in development, the embryonic ectoderm becomes subdivided along the mediolateral axis into 
neural, neural plate border and epidermal territories. From the neural plate border (that will later 
constitute the dorsal most region of the neural tube), the neural crest cells (NCCs) are specified 
through a series of steps controlled by different signaling pathways. At the early blastula stage, Wnt 
and BMP signals interact to block neural fate and to induce epidermal fates [95–97]. At the late blastula 
stage, non-instructive Wnt activity mediates the temporal exposure of epiblast cells to BMP signals 
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that specify neural plate border cells, and a later phase of Wnt activity, corresponding to the late 
gastrula stage, induces caudal/neural crest character in prospective neural plate border cells [98]. 
In Xenopus embryos, tissue expressing anterior neural plate border markers, induced by 
intermediate levels of BMP activity, was transformed into neural crest by posteriorizing signals, such 
as bFGF, Wnt-8 or RA treatment [97]. This transformation of the anterior neural plate border into 
NCCs can also be achieved in whole embryos, by RA treatment or by a constitutively active form of 
RARs [97]. Conversely, neural crest induction in vitro was inhibited by the expression of the dominant 
negative forms of the FGF receptor, DN-RAR and Wnt signaling effectors [97]. Similarly, in Raldh2−/− 
mutant embryos, a decrease in the expression of genes involved in dorsal spinal cord specification, 
such as Msx1 and Pax3, has been observed [49]; and in VAD quails, Pax7 is absent at the neural plate 
border, and there is a drastic reduction in NCCs markers, such as Snail2 and Sox9 [94]. However, these 
defects may be due to early caudal patterning alterations, as Raldh2−/− mutant embryos show an 
expansion of primitive streak and mesodermal markers (Follistatin and Brachyury) at the expense of 
markers of the prospective neuroepithelium, such as Sox2 [49]. It has been therefore suggested that RA 
signaling is required for the earliest steps in dorsal and NCC specification during gastrulation, before 
the RA activity appears in the dorsal neural tube [94], but RA signaling may also contribute at 
subsequent steps in NCC development. 
As mentioned in Section 2.1, when the first somites appear and as the embryo elongates, RA-responsive 
cells in mouse and in chicken embryos (Figure 1b,c) can be observed in the neural tube adjacent to 
formed somites. NCCs are a multipotent transient population that, at trunk levels, give rise to sensory 
neurons and glia, sympathetic neurons and melanocytes, amongst others [99]. To reach that diversity, 
after being specified, NCCs undergo a process of epithelium to mesenchyme transition (EMT) that 
confers them the ability to delaminate and migrate away from the dorsal neural tube. The development 
of trunk NCCs is highly coordinated with the development of adjacent somites, which impose a 
segmented migration and organization to the trunk NCCs and to the derived peripheral nervous 
system. Opposite the presomitic mesoderm, NCCs are confined to the dorsal neural tube, whereas 
NCC emigration begins facing epithelial somites [100,101].  
At trunk levels, it has been shown that a BMP-Wnt1 signaling cascade controls NCC emigration 
from the neural tube [101,102]. The regulation of that cascade is exerted through the caudal  
(high)-rostral (low) gradient of the BMP inhibitor, Noggin, which, in turn, is controlled by signals 
coming from the somites [103]. More recently, it has been established that one of the somite signals 
controlling NCC emigration from the neural tube is RA [94] (Figure 1f). Overexpression of DN-RAR 
caused a reduction in the number of cells expressing Sox10, and there was a dramatic delay in the 
emigration of Sox10+ NCCs. However, the initiation of the expression of Snail2 and FoxD3, early 
markers of NCC specification, was not affected, indicating that RA is required to establish the onset of 
NCC emigration independently of NCC specification. 
Conversely, FGF4/8 maintain dorsal neural tube cells uncommitted with respect to neural crest fate, 
and an FGF signaling decrease is necessary to promote not only NCC specification (as discussed 
above), but also subsequent migration from the neural tube [94]. Moreover, in relation to the BMP/Wnt 
signaling cascade operating in the dorsal neural tube, it has been established that RA signaling 
activation in the neural tube adjacent to somitic level coincides with the initiation of Wnt1 expression. 
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Whereas RA signaling triggers the initiation of Wnt1 expression in the dorsal neural tube at levels 
where the NCCs are already specified, FGF signaling prevents the premature expression of Wnt1 [94]. 
The actual view is that there is a short time window during which the onset of the NCC emigration 
can be tuned, once NCCs have acquired the essential specification program. That window coincides 
with the region where FGF and RA gradients collide, and it is required to keep the emergence of 
peripheral nervous system progenitors in register with the programs of spinal cord neurogenesis and 
somite development during trunk elongation. It remains to be seen if changes in the onset of emigration 
(that alter migratory behavior; [94]) will have consequences in the final differentiation of the NCCs. 
Once trunk NCCs emigrate from the dorsal neural tube, they will migrate along characteristic 
pathways to differentiate into a wide variety of derivatives according to their D-V position within the 
neural tube and the order of emigration [104]. NCCs interact with various extracellular matrix 
components and acquire specific competences to properly sense the cues they find along their 
pathways. Amongst the proteins relevant for this process are integrins that form clusters in focal 
adhesions in migrating cells. Little is known about the possible implications of RA signaling during 
trunk NCC migration. Recently, it has been established that the motile capacity of multipotent NCCs is 
governed in part by an RA-controlled dynamic regulation of Nedd9 levels (a member of the  
β-integrin signaling pathway), which influence cell adhesion and cytoskeleton properties [105]. It has 
been determined that the Nedd9 promoter contains a RARE site that interacts with the RA  
receptor [106]. It would be interesting to determine if some of the phenotypes described below for 
NCC-derived structures in conditions of vitamin A or retinoid insufficiency might be explained by 
deficiencies in Nedd9 expression [107,108]. 
RA signaling could also play a role in the terminal differentiation of the NCCs, once they reach 
their final destination. That could be the case for the neural cells that form the enteric nervous system 
(ENS). The ENS derives from the NCC precursors that colonize the bowel and differentiate into a 
network of neurons and glia that control intestinal function. There are several pieces of evidence that 
RA is essential for normal ENS development. Aganglionosis of the bowel (a Hirschsprung disease-like 
phenotype due to vagal crest deficiency) has been observed in Raldh2-deficient mice that had been 
partially “rescued” by treatment of the pregnant mothers with RA [109]. More recently, reduced colon 
myenteric neuron density and reduced colon myenteric neuron-to-glia ratio was observed in Raldh1−/−, 
Raldh2+/− and Raldh3+/− mutant mice [110]. Those alterations are unlikely to be due to defective ENS 
precursor migration, since the Raldh-combined mutant mice have increased enteric neuron progenitor 
migration into the distal colon compared to wild-type embryos during development.  
Finally, the crucial role of RARs in NCC-derived craniofacial structures, which originate from 
diencephalon to hindbrain levels, has been established for years [111–113] and has been discussed in 
other reviews [114]. The discussion about those aspects is out of the scope of this review chapter. 
6. RA and the Acquisition of Rostro-Caudal Identities in the Spinal Cord 
6.1. RA and the Specification of Spinal Cord Progenitor Cells 
RA has a predominant role in the regionalization of the nervous system along the R-C axis, mostly 
in the hindbrain and in the spinal cord, although an early role in forebrain patterning has also been 
described [115,116]. The regionalization of the nervous system is a progressive process initiated at 
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early stages when the neural plate is being established. Initially, most cells in the neural plate express 
markers that will later get restricted to the forebrain territory (i.e., Otx2), and as development proceeds 
caudal markers appear. Thus, caudally located cells are initially specified with a forebrain character, 
and at later stages, they display a midbrain, hindbrain or spinal cord character [2,23,117]. 
The ability to acquire caudal identities is highly dependent on the interaction of the neural plate 
with surrounding tissues. Initially, signals from Hensen’s node promote midbrain and hindbrain fates, 
and later, signals from the presomitic mesoderm promote the expression of spinal cord markers, such 
as Hoxb8, which is expressed in the presumptive spinal cord with a rostral limit around the level of 
somites 5–6 [95] and later extends rostrally into the hindbrain [118]. Molecules that promote midbrain, 
hindbrain and spinal cord identities are FGF, Wnts and RA. The functions of these signals along the R-
C axis vary depending on the signaling context (i.e., the competence of the tissue). For instance, FGF 
is able to promote a midbrain character, whereas a combination of FGF and Wnts promotes a rostral 
hindbrain character (i.e., rhombomeres r1–5; [95]). More caudal hindbrain (r6–8) and spinal cord 
characters can be promoted by RA and Wnt signaling [119]. Extensive literature is devoted to the role 
of RA in hindbrain patterning [44] and will not be analyzed in this review. However, some 
mechanisms may be shared with spinal cord patterning.  
Active RA signaling from the presomitic mesoderm is required for Hoxb8 expression in chick 
spinal cord explant cultures, and RA in combination with signals from early mesoderm promotes 
Hoxb8 expression, suggesting a role of RA in spinal cord specification [23,119]. However, as 
expression of Hoxb8 later extends into the hindbrain in an RA-dependent manner [118], its activation 
in explants may reflect this second phase of expression. In fact, Hoxb8 is expressed in VAD  
quails [120] and, similarly, Raldh2−/− embryos and chicken neural tube electroporated with DN-RAR 
show normal Hoxb8, Hoxb6 and Hoxb7 expression in spinal cord progenitors ([49]; Bel-Vialar, 2002 
#5972), suggesting that RA is not required for Hoxb8 expression in the spinal cord. Interestingly, 
Raldh2−/− embryos show an early decrease in the expression of the caudal specific genes Cdx1 and 
Hoxb9 (characteristic of caudal spinal cord), confirming an RA requirement in some aspects of spinal 
cord identity [49]. Normal expression of Cdx1 seems to require direct binding of RAR to a Cdx1 
RARE sequence [121]. However, the molecular mechanism responsible for the regulation of Hoxb9 by 
RA in the spinal cord is not known, but may involve RARE sequences, as has been shown for the 
expression of Hox genes in the hindbrain [122]. 
Furthermore, the relationship of Cdx1 and RA may be further complicated. In zebrafish embryos, 
Cdx1a/4 morpholino treatment causes a posterior shift of the Raldh2 expression domain in the 
paraxial/lateral mesoderm, resulting in overlapping regions of high FGF and RA signaling in the 
caudal neural tissue [123]. This alteration is probably behind the ectopic formation of the posterior 
hindbrain and anterior spinal cord at the caudal neural tube and the severe posterior truncation 
observed in cdx1a/4 morphants. 
The picture that emerges is that the early exposure of the caudal neural plate progenitors to RA is 
required for the acquisition of some spinal cord properties. Then, an RA-free region has to be established 
caudally for further caudal spinal cord specification, in order to allow the action of caudalizing signals, 
such as increasing FGF levels and GDF11 [117], and the expression in early caudal spinal cord 
progenitors of Hoxc9 (expressed caudally to somite 20) [119]. Finally, the subsequent progressive 
exposure to RA produced by somites will not alter the established Hox code in spinal cord progenitors [124]. 
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6.2. RA in the Acquisition of Rostro-Caudal Column Identities of Motor Neurons 
The heterogeneity of the spinal cord along its R-C axis is functionally relevant. For example, 
different MN subtypes organized in columns can be specified depending on their position along the  
R-C axis. Thus, at cervical regions, neurons of the phrenic motor column (PMC) innervating the 
diaphragm differentiate; at limb forming regions (brachial and lumbar), neurons of the lateral motor 
column (LMC) form to innervate limbs; and at thoracic levels, neurons of the preganglionic motor 
column (PGC or Column of Terni in the chick) that innervate sympathetic motor neurons and neurons 
of the hypaxial motor column (HMC; also known as the lateral medial motor column or MMCL) 
innervating hypaxial muscles are specified [125] (Figure 1h). These differences along the R-C axis are 
related to the differential expression of Hox genes, first in progenitors, as shown above, and, 
subsequently, in the resulting MNs. Whereas, Hoxc5 is expressed in cervical and caudal brachial MN, 
Hoxc6 is expressed in brachial MNs, Hoxc8 in caudal brachial MN and Hoxc9 in thoracic MN [117]. 
The acquisition of the different R-C neuronal subtypes within the spinal cord has been related to 
signals from the Hensen’s node and paraxial mesoderm [73,117,126]. In particular, cervical-level 
paraxial mesoderm can promote cervical characteristics (Hoxc5) that can be blocked by RAR 
antagonists [117], suggesting a role for RA in the specification of cervical MNs. Most importantly, 
removal of Raldh2 from both trunk mesoderm and spinal cord progenitors from stages E10.5 causes a 
decrease in Hoxc6 and Hoxc8 expression at brachial levels, supporting its requirement for brachial MN 
differentiation [12]. This change in Hox gene expression may account for some of the changes in 
motor column programs observed in RA-deficient conditions. Electroporation of DN-RAR in brachial 
motor neurons results in the loss of LMC columns, defined by their expression of Raldh2 and in the 
ectopic differentiation of motor neurons characteristic of thoracic regions (PGC; [14]), supporting a 
role for RA in inducing generic LMC properties. However, the interference with RAR at lumbar levels 
does not affect generic LMC specification [14], suggesting that other mechanisms regulate the generation 
of LMC at lumbar regions (see [127]). 
RA is not only required, but can also increase the number of Hoxc5 expressing MN in spinal cord 
explants that have not yet acquired their Hoxc neuronal identities [117]. Moreover, RA alters the fate 
of MNs derived from thoracic spinal cord explants, increasing the number of MNs that express 
brachial-specific Hoxc6 [117] and blocking the production of Hoxc9+ thoracic MNs [117]. Furthermore, 
sustained ectopic activation of RA by electroporation of a constitutively active RAR in thoracic motor 
neurons impairs the differentiation of PGC and HMC neurons, leading to MN apoptosis [14]. 
Interestingly, RA is also important within both brachial and lumbar regions for the proper 
diversification of the LMC neurons into lateral LMC neurons that project to dorsal targets and medial 
LMC neurons that project ventrally (Figure 1i). All LMC neurons express initially Isl1, but this is 
downregulated in the lateral LMC neurons as they initiate Lim1 expression. RA favors lateral LMC 
fates, as it promotes Lim1 expression and downregulates Isl1 [73], which, in turn, control Ephrin 
production, which allows cells to differentially project to their targets [128]. Raldh2−/− mutants rescued 
from early lethality by RA supplementation from E7.5 to 8.5 show changes in the MN fates at brachial 
levels compatible with a change of fate from lateral to medial LMC when analyzed at E12.5 [83]. 
Specific removal of Raldh2 from paraxial mesoderm, which results in a 50% decrease in RA levels in 
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the spinal cord, only slightly decreases MN production, but provokes a large reduction in the number 
of lateral LMC both at brachial and lumbar levels [13]. 
Both activities of RA in the specification of brachial LMC and in the subsequent diversification of 
LMCs into lateral and medial populations could be exerted through the control of Nolz transcription, 
which is activated by retinoids [129]. This transcription factor specifies LMC identity by inducing the 
expression of the postmitotic LMC determinant Hoxc6 and later contributes to specification of lateral 
LMC identity through Lim1 induction [129]. 
An additional role for RA in the maintenance and survival of both medial and lateral LMCs and in 
axonal projections has also been suggested. The specific removal of Raldh2 from MNs results in a 
decrease of medial and lateral LMC neurons and abnormal axonal projections to the limb [13].  
These multiple requirements for RA in MN differentiation could be related to the dynamic Raldh2 
pattern of expression (Figure 1h,i). At the time of MN generation, Raldh2 is expressed in somites, 
from where it promotes the specification of MN progenitors (Figure 1c,e) and their progression to 
differentiation (Figure 1g). Moreover, Raldh2 is especially high at the cervical/brachial levels, where it 
promotes cervical/brachial versus thoracic MN specification [14]. Finally, the expression of Raldh2 
increases in lumbar paraxial mesoderm levels and also is expressed in brachial and lumbar LMC MNs, 
resulting in high signaling levels that promote the diversification of LMC neurons into lateral and 
medial fates [14] and the survival of all LMC neurons.  
Figure 1. Retinoic acid (RA) functions in spinal cord development. At gastrulation (a) and 
early somite (b) chick stages, Raldh2 is expressed in the paraxial mesoderm underlying the 
presumptive hindbrain and spinal cord. RA is involved in the acquisition of spinal cord 
properties. At these stages, it may also allow the activation of dorsal-specific genes.  
(c,d–f) Around the 10-somite stage, Raldh2 is produced in the somites (at lower levels in 
s1–4) and RA is involved in several processes shown in the cross sections (d–f), such as 
early neurogenesis (d), establishment of ventral progenitor domains (e) and neural crest 
emigration (f). (g) At the 40-somite stage, the expression of Raldh2 is restricted to the 
dermomyotome component of somites, and it is initiated in the roof plate and in motor 
neuros (MNs) of the lateral motor column (LMC) at the brachial and lumbar levels. 
Around these stages, RA is involved in the progression of neuronal differentiation.  
(h) Around the 36-somite stage, Raldh2 is highly expressed in somites at cervical/brachial 
levels. RA is involved here in the specification of brachial MN and, in particular, in the 
LMC MNs. (i) At around the 40-somite stage, Raldh2 is expressed specifically in LMC 
MNs and continues to be expressed in somites. RA promotes the diversification of LMC 
neurons, promoting a lateral LMC fate. HH, Hamburger and Hamilton; MMC, medial 
motor column; PMC, phrenic motor column; HMC, hypaxial motor column; PGC, 
preganglionic motor column. 
J. Dev. Biol. 2014, 2 188 
 
 
J. Dev. Biol. 2014, 2 189 
 
7. Conclusions 
The actual view in the field is that RA signaling has essential and diverse roles during spinal cord 
development, from early specification and patterning of neural progenitors to the progression to the 
differentiation and diversification of neuronal subtypes. For that reason, a careful consideration of the 
most appropriate RA experimental manipulation procedure is needed to reach precise conclusions 
about RA-specific roles and mechanisms of action. For instance, the requirement of RA for the 
expression of dorsal patterning genes may be the result of a defective spinal cord specification or 
reflect a later role in specification or maintenance of dorsal identity. 
Given the complexity of RA activity, several questions remain open in the field. An important 
challenge is to determine the sequence of direct gene activation events attributed to changes in RA 
signaling levels. Several studies have led to novel insights into the interplay between RA and other 
signaling pathways (such as FGF, Hedgehog, TGF) in several developing systems. However, better 
knowledge of the immediate early RA target genes is necessary to clarify whether there are common 
regulatory networks, rather than specific gene targets, for each system. 
It will be important to further improve live imaging tools to accurately monitor endogenous RA 
activity gradients across embryonic development at the cellular level [47]. These tools, in combination 
with the identification of the mechanisms controlling the expression of enzymes involved in RA production 
and degradation, as well as of the positive and negative feedback loops, should provide a better 
understanding of the dynamics and fine-tuning of RA signaling levels throughout development. 
Finally, RA has been shown to promote specific MN fates in embryonic stem cells [70] and constitutes 
an important reagent for exploring the disease sensitivity of motor neuron subtypes in vitro [130,131]. 
The advances in the understanding of the function of RA during normal neurogenesis and the 
acquisition of neuronal subtype identities will provide essential information for the field of 
neurodegenerative and regenerative medicine and may contribute to the establishment of treatments for 
damaged or aged human spinal cord, based on the introduction of differentiated cells produced in vitro 
from embryonic stem cells or induced pluripotent stem cells. 
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